The biotechs have been living in the shade of the resources boom...

The biotechs have been living in the shade of the resources boom of late but quite a few have come off their lows of late culminating in BLR's stellar rise(shame I
wasn't on it).
So which down-and-outs could be the next to run?
Here are a few that are hanging round their lows:-
SOM - Somnomed actually has an FDA approved
sleep anoea device but is trading at 2c
NAL - a recent company announcement stated that
their holding in a subsidiary is worth 10c a share alone
while they are hanging around 6c.
NRT - this one is a mystery to me - it traded at $8
a few years ago and has fell to under $3 on only
good news(IMHO) such as the FDA approved trials of it's cancer traetment drug and it's chairman recently announced that it was "extraordinary value at these levels".

Any more?

N.B. As you may have guessed, I hold all 3 of these
stocks so don't take my word for it(I am not a financial
adviser) and do your own research.